Application Nr Approved Date Route Status External Links
NDA050592 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Tobramycin And Dexamethasone Ophthalmic Suspension Is Indicated For Steroid-Responsive Inflammatory Ocular Conditions For Which A Corticosteroid Is Indicated And Where Superficial Bacterial Ocular Infection Or A Risk Of Bacterial Ocular Infection Exists. Ocular Steroids Are Indicated In Inflammatory Conditions Of The Palpebral And Bulbar Conjunctiva, Cornea And Anterior Segment Of The Globe Where The Inherent Risk Of Steroid Use In Certain Infective Conjunctivitides Is Accepted To Obtain A Diminution In Edema And Inflammation. They Are Also Indicated In Chronic Anterior Uveitis And Corneal Injury From Chemical, Radiation Or Thermal Burns, Or Penetration Of Foreign Bodies. The Use Of A Combination Drug With An Anti-Infective Component Is Indicated Where The Risk Of Superficial Ocular Infection Is High Or Where There Is An Expectation That Potentially Dangerous Numbers Of Bacteria Will Be Present In The Eye. The Particular Anti-Infective Drug In This Product Is Active Against The Following Common Bacterial Eye Pathogens: Staphylococci, Including S. Aureus And S. Epidermidis (coagulase-Positive And Coagulase-Negative), Including Penicillin-Resistant Strains. Streptococci, Including Some Of The Group A-Beta-Hemolytic Species, Some Nonhemolytic Species, And Some Streptococcus Pneumoniae . Pseudomonas Aeruginosa, Escherichia Coli, Klebsiella Pneumoniae, Enterobacter Aerogenes, Proteus Mirabilis, Morganella Morganii, Most Proteus Vulgaris Strains, Haemophilus Influenzae And H. Aegyptius, Moraxella Lacunata, Acinetobacter Calcoaceticus And Some Neisseria Species.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Dexamethasone DEXAMETHASONE ZINC4654654
2. Tobramycin TOBRAMYCIN ZINC8214692

Comments